Connected Drug Delivery Devices Market Size, Share & Trends Analysis Report By Product, By End Use (Healthcare Providers, Homecare), By Technology (Bluetooth, NFC), By Region, And Segment Forecasts, 2020 - 2027

Table of Content

Chapter 1 Methodology And Scope
1.1 Market Segmentation And Scope
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation And Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.7 List Of Secondary Sources
1.8 Report Objectives
Chapter 2 Executive Summary
2.1 Connected Drug Delivery Devices Market Outlook, 2016 - 2027 (USD Million)
2.2 Market Snapshot
Chapter 3 Global Connected Drug Delivery Devices: Market Variables, Trends & Scope
3.1 Market Driver Analysis
3.1.1 Increased Patient Connectivity And Engagement
3.1.2 Rising Patient Awareness About Adherence To Prescribed Therapies
3.2 Market Restraint Analysis
3.2.1 Increased Cost Of Devices
3.2.2 Increasing Concerns About Data Privacy And Transfer
3.3 Global Connected Drug Delivery Devices Market- SWOT Analysis, by Factor (Political & legal, Economic and Technological)
3.4 Industry Analysis - Porter’s
Chapter 4 Connected Drug Delivery Devices Market: Competitive Analysis
4.1 Innovators
4.2 Competitive Insights
4.2.1 Heat Map Analysis
4.2.2 Covid-19 Impact
4.2.2.1 Opportunity Analysis
4.2.3 List Of Key Players
4.3 Healthcare App Development Cost Analysis
4.4 List of Healthcare App Development Companies
4.5 Project and Annual Maintenance Cost Analysis
Chapter 5 Global Connected Drug Delivery Devices Market: Types Estimates & Trend Analysis
5.1 Global Connected Drug Delivery Devices Market: Type Movement Analysis
5.2 Connected Sensors
5.2.1 Market Estimates And Forecasts, 2016 - 2027 (USD Million)
5.2.2. Connected Inhaler Sensors
5.2.2.1 Market Estimates And Forecasts, 2016 - 2027 (USD Million)
5.2.3 Connectable Injection Sensors
5.2.3.1 Market Estimates And Forecasts, 2016 - 2027 (USD Million)
5.3 Integrated Connected Devices
5.3.1 Market Estimates and Forecasts, 2016 - 2027 (USD Million)
5.3.2 Connected Inhalation Devices
5.3.2.1 Market Estimates and Forecasts, 2016 - 2027 (USD Million)
5.3.3 Connected Injection Devices
5.3.3.1 Market Estimates and Forecasts, 2016 - 2027 (USD Million)
Chapter 6 Global Connected Drug Delivery Devices Market: End-use Estimates & Trend Analysis
6.1 Global Connected Drug Delivery Devices Market: End-use Movement Analysis
6.2 Healthcare Providers
6.2.1 Market estimates and forecasts in the healthcare providers segment, 2016 - 2027 (USD Million)
6.3 Homecare
6.3.1 Market estimates and forecasts in homecare segment, 2016 - 2027 (USD Million)
Chapter 7 Global Connected Drug Delivery Devices Market: Technology Estimates & Trend Analysis
7.1 Global Connected Drug Delivery Devices Market: Technology Movement Analysis
7.2 Bluetooth
7.2.1 Market Estimates And Forecasts, 2016 - 2027 (USD Million)
7.3 NFC
7.3.1 Market Estimates And Forecasts, 2016 - 2027 (USD Million)
7.4 Other Technologies
7.4.1 Market Estimates And Forecasts, 2016 - 2027 (USD Million)
Chapter 8 Global Connected Drug Delivery Devices Market: Regional Estimates & Trend Analysis, By Product, Technology, And End-Use
8.1 Global Connected Drug Delivery Devices Market: Regional Movement Analysis
8.2 North America
8.2.1 Market Estimates And Forecasts, 2016 - 2027 (USD Million)
8.2.2 U.S.
8.2.2.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
8.2.3 Canada
8.2.3.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
8.3 Europe
8.3.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
8.3.2 U.K.
8.3.2.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
8.3.3 Germany
8.3.3.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
8.3.4 France
8.3.4.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
8.3.5 Italy
8.3.5.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
8.3.6 Spain
8.3.6.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
8.4 Asia Pacific
8.4.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
8.4.2 Japan
8.4.2.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
8.4.3 China
8.4.3.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
8.4.4 India
8.4.4.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
8.5 Latin America
8.5.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
8.5.2 Brazil
8.5.2.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
8.5.3 Mexico
8.5.3.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
8.6 MEA
8.6.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
8.6.2 South Africa
8.6.2.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
8.6.3 Saudi Arabia
8.6.3.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
Chapter 9 Company Profiles
9.1 Propeller Health
9.1.1 Company Overview
9.1.2 Financial Performance
9.1.3 Product Benchmarking
9.1.4 Strategic Initiatives
9.2 Proteus Digital Health
9.2.1 Company Overview
9.2.2 Financial Performance
9.2.3 Product Benchmarking
9.2.4 Strategic Initiatives
9.3 BIOCORP
9.3.1 Company Overview
9.3.2 Financial Performance
9.3.3 Product Benchmarking
9.3.4 Strategic Initiatives
9.4 Merck KGaA
9.4.1 Company Overview
9.4.2 Financial Performance
9.4.3 Product Benchmarking
9.4.4 Strategic Initiatives
9.5 Adherium Limited
9.5.1 Company Overview
9.5.2 Financial Performance
9.5.3 Product Benchmarking
9.5.4 Strategic Initiatives
9.6 West Pharmaceutical Services, Inc.
9.6.1 Company Overview
9.6.2 Financial Performance
9.6.3 Product Benchmarking
9.6.4 Strategic Initiatives
9.7 Aterica
9.7.1 Company Overview
9.7.2 Financial Performance
9.7.3 Product Benchmarking
9.7.4 Strategic Initiatives
9.8 Phillips Medisize
9.8.1 Company Overview
9.8.2 Financial Performance
9.8.3 Product Benchmarking
9.8.4 Strategic Initiatives
9.9 FindAir
9.9.1 Company Overview
9.9.2 Financial Performance
9.9.3 Product Benchmarking
9.9.4 Strategic Initiatives
Chapter 10 KoL Transcript